project id: TCGA-LUAD; case submitter id: TCGA-50-5941; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 55; days to birth: -20350; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 20350; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1474.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; composition: Not Reported; intermediate dimension: 1.0; longest dimension: 1.0; preservation method: Unknown; shortest dimension: 0.3; sample id: 91719392-76ce-479f-ba05-e43bf0201cc4; sample submitter id: TCGA-50-5941-01A; portion id: e5ddceb5-b425-4414-907b-0f60b97402c2; portion submitter id: TCGA-50-5941-01A-11; percent lymphocyte infiltration: 10.0; percent neutrophil infiltration: 5.0; percent tumor nuclei: 71.0;